Related Experiment Video
Updated: Jul 19, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Sudden death prevention in heart failure
Mariana Machado1, L Menezes Falcão, Luciano Ravara
1Serviço de Medicina I, Hospital de Santa Maria, Lisboa, Portugal. marianavmachado@hotmail.com
Abstract:
Heart failure is one of the main clinical entities in modern society, with a prevalence of 0.4 to 2% in Europe. It has an adverse prognosis, with 5 to 20% annual mortality, even when properly medicated. Mortality in heart failure is frequently due to sudden death, which means preventive strategies should be adopted. Risk stratification is essential in order to identify which patients will benefit most. The main risk factor for sudden death is low ejection fraction. However, ECG data, Holter monitoring and electrophysiological studies are also useful. In primary prevention, all reversible conditions and precipitating factors should be identified and heart failure treatment optimized. The best preventive strategy, after appropriate patient selection, is ICD implantation. Recently, devices with both cardioversion-defibrillation and cardiac resynchronization have proved beneficial in terms of morbidity, quality of life and survival.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: β-Blockers
Cardiopulmonary Resuscitation III: AED Use
